Skip to main content
. Author manuscript; available in PMC: 2012 Jan 3.
Published in final edited form as: Clin Pharmacol Ther. 2011 Aug 31;90(4):568–574. doi: 10.1038/clpt.2011.194

Figure 1.

Figure 1

Association of (a,b) PON1 Q192R variant (rs662) and (c,d) CYP2C19*2 (rs4244285) with adenosine diphosphate–stimulated platelet aggregation before and after clopidogrel treatment in participants of the Amish Pharmacogenomics of Anti-Platelet Intervention study. The horizontal line within each box indicates the median; the top and bottom borders of each box indicate the interquartile range (IQR). The whiskers extending from each box indicate ± 1.5 IQRs; the points beyond the whiskers indicate outliers beyond 1.5 IQRs.